OMNICELL, INC., BD and McKesson Corporation are Dominating the Global Pharmacy Automation Market in 2019

Global Pharmacy Automation Market is expected to grow with the CAGR of 8.1% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-pharmacy-automation-market

Global pharmacy automation market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global pharmacy automation market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in February 2020, Parata Systems launched its new pouch packager named PASS 36. The new product with various benefits launched by the company has increased its demand and sales in the market.

OMNICELL, INC. is the dominating player in global pharmacy automation market. The other key players existing in the market includes Talyst, LLC., ARxIUM, Cerner Corporation, Capsa Healthcare, Parata Systems, LLC, ScriptPro LLC, RxSafe, LLC., RxMedic Systems, Inc., MedAvail Technologies, Inc., Asteres Inc., PerceptiMed, Inc., BD, Baxter, Fullscript, McKesson Corporation, Innovation Associates, AmerisourceBergen Corporation, vitabook GmbH, UNIVERSAL LOGISTICS HOLDINGS, INC, Takazono Corporation, TOSHO co., Inc., Gebr. Willach GmbH, Global Healthcare Exchange, LLC., BIQHS, Grifols, S.A., Synergy Medical, Yuyama, APD Algoritmos Procesos y Diseños S.A, JVM Europe BV, Mediwell Systems Ltd., E-SANTÉ Technology, Genesis Automation LTD, PHARMAGEST INTERACTIVE, Best Health Solutions, myPak Solutions Pty Ltd., Mexx Engineering, Meditec Pty Ltd., FarmaTools, Demodeks Pharmacy Shelving, Deenova S.r.l., MEKAPHARM, KUKA AG, Rohmann-Automation GmbH, KLS Pharma Robotics GmbH, Technology Implementation and Management Experts and Med Management, among others.

Pharmacy Automation Market OMNICELL, INC.

OMNICELL, INC. was incorporated in 1992 and is headquartered in California, U.S. The company focuses on providing data-driven, automated medication management and adherence solutions that enable health systems, hospitals, and pharmacies worldwide in order to play an important role in patient care and population health. The company is providing products under focuses on providing data-driven, automated medication management and adherence solutions that enable health systems, hospitals, and pharmacies worldwide in order to play an important role in patient care and population health product categories. The market focus products lie under intelligence, central pharmacy dispensing, central pharmacy IV Compounding, point of care, medication adherence and population health product category. The company is engaged in continuous development of pharmacy automation.

  • In August 2020, OMNICELL, INC. entered into an agreement Pharmaceutical Strategies Group (PSG) in order to acquire its 340B Link business. This acquisition will increase the software-enabled services and solutions of the company leading to increased sales and revenue in future.

The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company has various subsidiaries like Aesynt Pty Ltd. (Australia), Omnicell GmbH (Germany), Omnicell SAS (France), Omnicell Ltd. (U.K.) and Aesynt B.V (The Netherlands), among others.

BD

BD is headquartered in New Jersey, U.S., was incorporated in 1897. The company is engaged in the development, manufacturing and sale of a wide range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company has multiple business segments such as medical, life sciences and interventional, in which medical is the market focused segment. The company is providing products under anesthesia delivery, biosciences, biosurgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation, home care, infection prevention, infusion therapy, interventional specialties, lab automation, medication and supply management, microbiology solutions, molecular diagnostics, patient monitoring and temperature management, prostate health, respiratory care, sharps disposal solutions, software solutions, specimen collection, surgical instruments, syringes and needles, urology and kidney health, vascular access, vascular surgery, wound care. The market focus products lie under medication and supply management product category. The company is engaged in continuous development of pharmacy automation.

  • In December 2014, BD’s acquired company CareFusion launched its new innovations in order to expand its capabilities of its enterprise-wide medication management solutions for usage in the hospitals and outpatient settings. The new product launched includes Pyxis Mini system. This new innovation launched by the company has strengthened its pharmacy automation systems portfolio.

The company has wide presence across Europe, North America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies such as Accuri Cytometers, Inc.(Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware), B-D (Cambridge U.K.) Ltd. (U.K.), among others.

McKesson Corporation

McKesson Corporation was founded in 1833. The company focuses on providing healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. The company is engaged in providing products in categories like pharmaceutical distribution, wholesale medical supplies, pharmacy services & technology, solutions for specialty practices and solutions for biopharma among which pharmaceutical distribution, pharmacy services & technology and solutions for specialty practices are the market focused categories.

  • In February 2018, McKesson Corporation collaborated with Creative Pharmacist, a U.S. based pharmacist launch clinical service in order to enhance the clinical programme for community pharmacies. This collaboration has strengthened the pharmacy management systems of the company leading to its increased demand in the market.

The company has wide presence across Europe and North America.The company has various subsidiary companies such as ClarusONE Sourcing Services LLP (U.K.), McKesson Europe AG (Germany), McKesson Medical-Surgical Inc. (U.S.), McKesson Strategic Services Limited (U.S.) and US Oncology Holdings, Inc. (U.S.), among more. The company has initiated many strategic initiatives to expand its market.